Among different cytokines increased in such exacerbated response (5), Interleukin-6 (IL-6) in serum is mainly expected to predict the severity of SARS-CoV-2 pneumonia, as suppression of pro-inflammatory IL-6 have been shown to have a therapeutic effect in many inflammatory diseases, including viral infections (6). This evidence concerns the gene IL6 and viral infectious disease.